Development Level

Tbio 7 | 10,625
Tchem 4 | 1,890
Tclin 1 | 602

IMPC Phenotype

embryonic lethality prior to t... 2 | 187
preweaning lethality, complete... 2 | 633
abnormal body wall morphology 1 | 7
abnormal embryo size 1 | 112
abnormal motor learning 1 | 4
abnormal retina morphology 1 | 100
abnormal retinal vasculature m... 1 | 15
cataract 1 | 26
cleft palate 1 | 6
enlarged heart 1 | 111
immune system phenotype 1 | 17
increased startle reflex 1 | 38
limb grasping 1 | 35

Disease

Cancer 6 | 2,346
psoriasis 6 | 6,685
group 3 medulloblastoma 5 | 2,254
malignant mesothelioma 5 | 3,163
Breast cancer 4 | 3,098
Cleft Lip 4 | 91
Cleft palate 4 | 125
invasive ductal carcinoma 4 | 2,950
lung cancer 4 | 4,473
medulloblastoma, large-cell 4 | 6,234
osteosarcoma 4 | 7,933
ovarian cancer 4 | 8,491
Achondroplasia 3 | 20
Craniosynostosis 3 | 47
Down syndrome 3 | 548
LADD syndrome 3 | 9
Parkinson's disease 3 | 364
Synostosis 3 | 18
breast carcinoma 3 | 1,614
diabetes mellitus 3 | 1,663
non-small cell lung cancer 3 | 2,798
oligodendroglioma 3 | 2,849
pituitary cancer 3 | 1,972
Acrocephalosyndactylia 2 | 15
Diaphragmatic Hernia 2 | 40
Heart disease 2 | 279
Hypogonadotropic hypogonadism 2 | 20
Kallmann Syndrome 2 | 33
Klinefelter's syndrome 2 | 59
Mesothelioma 2 | 40
Myocardial Ischemia 2 | 169
Polydactyly 2 | 93
Pulmonary Fibrosis 2 | 66
Vascular disease 2 | 281
atypical teratoid/rhabdoid tumor 2 | 1,095
colon cancer 2 | 1,475
cystic fibrosis 2 | 1,670
ductal carcinoma in situ 2 | 1,745
ependymoma 2 | 2,514
glioblastoma 2 | 5,572
interstitial cystitis 2 | 2,299
pediatric high grade glioma 2 | 2,712
pilocytic astrocytoma 2 | 3,086
ulcerative colitis 2 | 2,087
22q11 Deletion Syndrome 1 | 7
Acanthosis nigricans 1 | 14
Ankylosis 1 | 25
Autosomal dominant hypophosphatemic rickets 1 | 4
Bladder cancer 1 | 3
CHARGE syndrome 1 | 23
Cardiac Hypertrophy 1 | 4
Cardiomegaly 1 | 66
Cardiovascular Abnormalities 1 | 7
Cervical cancer 1 | 23
Cervix carcinoma 1 | 6
Colon Carcinoma 1 | 25
Congenital absence of kidneys syndrome 1 | 5
Corneal Neovascularization 1 | 2
DOID:0050532 1 | 2
Decubitus ulcer 1 | 10
Diabetic Retinopathy 1 | 53
FGF16 1 | 1
Fanconi syndrome 1 | 14
Fibrous dysplasia 1 | 15
Gastrointestinal system disease 1 | 50
Gliosis 1 | 16
Hamman-Rich syndrome 1 | 35
Hemangioma 1 | 35
Hemangiopericytoma 1 | 6
Hyperostosis 1 | 16
Hypochondroplasia 1 | 11
Hypotension 1 | 53
Keratinocytic non-epidermolytic nevus 1 | 2
Keratosis 1 | 34
Malignant tumor of urinary bladder 1 | 5
McCune Albright syndrome 1 | 19
Metacarpal 4-5 fusion 1 | 1
Myeloma, Multiple 1 | 6
NEVUS, EPIDERMAL (disorder) 1 | 4
Nephrotic Syndrome 1 | 48
Nevus, Epidermal 1 | 5
Opitz-GBBB syndrome 1 | 19
Oral Submucous Fibrosis 1 | 18
PARKINSON DISEASE, LATE-ONSET 1 | 20
Prenatal Exposure Delayed Effects 1 | 9
Proximal symphalangism 1 | 6
RENAL ADYSPLASIA 1 | 3
Retinal detachment 1 | 33
Retinal ischemia 1 | 5
Saethre-Chotzen syndrome 1 | 9
Sarcoma of soft tissue 1 | 11
Scotoma 1 | 7
Seminoma 1 | 15
Skin atrophy 1 | 13
Thanatophoric dysplasia 1 | 5
Type 1 diabetes mellitus 1 | 104
Upper respiratory tract disease 1 | 7
Uremia 1 | 19
Urinary system cancer 1 | 2
non-invasive bladder papillary urothelial neoplasm 1 | 4

Tissue

Blood and immune system 12 | 17,994
Cardiovascular System 12 | 17,957
Digestive Tract 12 | 18,472
Endocrine System 12 | 18,511
Female tissues 12 | 18,646
Liver and Pancreas 12 | 18,135
Nervous System 12 | 18,560
Skin and soft tissues 12 | 18,114
Urinary Tract 12 | 18,443
Male tissues 10 | 17,968
Respiratory system 9 | 17,483

Target Family

Non-IDG 11 | 11,969
Kinase 1 | 634

Reactome Pathway

Signaling by activated point m... 12 | 12
Signal Transduction 2,515 | 2,515
Immune System 2,183 | 2,183
Metabolism 2,131 | 2,131
Gene Expression 1,754 | 1,754
Metabolism of proteins 1,544 | 1,544
Innate Immune System 1,375 | 1,375
Signaling by GPCR 1,329 | 1,329
Developmental Biology 1,028 | 1,028
GPCR downstream signaling 1,015 | 1,015
Post-translational protein mod... 1,004 | 1,004
Adaptive Immune System 938 | 938
Disease 855 | 855
Generic Transcription Pathway 852 | 852
Cytokine Signaling in Immune s... 803 | 803
Metabolism of lipids and lipop... 797 | 797
Vesicle-mediated transport 705 | 705
Hemostasis 669 | 669
Transmembrane transport of sma... 668 | 668
Membrane Trafficking 608 | 608
Cell Cycle 572 | 572
Neutrophil degranulation 542 | 542
Axon guidance 541 | 541
Signaling by Interleukins 500 | 500
Cell Cycle, Mitotic 470 | 470
Signalling by NGF 467 | 467
GPCR ligand binding 456 | 456
Gastrin-CREB signalling pathwa... 435 | 435
Class I MHC mediated antigen p... 430 | 430
Olfactory Signaling Pathway 430 | 430
Fc epsilon receptor (FCERI) si... 423 | 423
Cellular responses to stress 415 | 415
DAP12 interactions 409 | 409
Infectious disease 391 | 391
NGF signalling via TRKA from t... 378 | 378
Signaling by Rho GTPases 378 | 378
Signaling by PDGF 367 | 367
Diseases of signal transductio... 359 | 359
Transcriptional Regulation by ... 356 | 356
Signaling by EGFR 355 | 355
Metabolism of amino acids and ... 353 | 353
DAP12 signaling 346 | 346
Downstream signal transduction 343 | 343
Neuronal System 343 | 343
Organelle biogenesis and maint... 334 | 334
Signaling by VEGF 329 | 329
Signaling by SCF-KIT 327 | 327
Class A/1 (Rhodopsin-like rece... 322 | 322
VEGFA-VEGFR2 Pathway 321 | 321
FCERI mediated MAPK activation 316 | 316
Signaling by Insulin receptor 312 | 312
Antigen processing: Ubiquitina... 301 | 301
Extracellular matrix organizat... 292 | 292
Signaling by Type 1 Insulin-li... 290 | 290
Signaling by Wnt 290 | 290
IGF1R signaling cascade 289 | 289
IRS-related events triggered b... 289 | 289
Insulin receptor signalling ca... 288 | 288
Metabolism of carbohydrates 288 | 288
DNA Repair 286 | 286
IRS-mediated signalling 285 | 285
MAPK family signaling cascades 283 | 283
Asparagine N-linked glycosylat... 282 | 282
Signaling by the B Cell Recept... 282 | 282
SLC-mediated transmembrane tra... 280 | 280
Deubiquitination 277 | 277
Interferon Signaling 275 | 275
Platelet activation, signaling... 274 | 274
NCAM signaling for neurite out... 268 | 268
M Phase 266 | 266
Interleukin-3, 5 and GM-CSF si... 262 | 262
RET signaling 261 | 261
Signalling to ERKs 254 | 254
Interleukin-2 signaling 253 | 253
Immunoregulatory interactions ... 252 | 252
RHO GTPase Effectors 249 | 249
VEGFR2 mediated cell prolifera... 249 | 249
Signalling to RAS 247 | 247
Interleukin receptor SHC signa... 246 | 246
G alpha (i) signalling events 245 | 245
Fatty acid, triacylglycerol, a... 244 | 244
Signaling by Leptin 244 | 244
Prolonged ERK activation event... 243 | 243
MAPK1/MAPK3 signaling 242 | 242
Frs2-mediated activation 241 | 241
HIV Infection 241 | 241
ARMS-mediated activation 240 | 240
Signalling to p38 via RIT and ... 240 | 240
Chromatin modifying enzymes 237 | 237
Chromatin organization 237 | 237
GRB2 events in EGFR signaling 236 | 236
RAF/MAP kinase cascade 236 | 236
SHC1 events in EGFR signaling 236 | 236
SOS-mediated signalling 236 | 236
Processing of Capped Intron-Co... 235 | 235
Biological oxidations 215 | 215
Keratinization 213 | 213
Transmission across Chemical S... 210 | 210
rRNA processing 209 | 209
Ion channel transport 204 | 204
Phospholipid metabolism 202 | 202

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Fibroblast growth factor 16 FGF16 Tbio Non-IDG -1.74106 54.5 120
Fibroblast growth factor 1 FGF1 Tchem Non-IDG -3.19895 1583.2 445
Fibroblast growth factor 2 FGF2 Tchem Non-IDG -3.99298 10115.4 658
Fibroblast growth factor 4 FGF4 Tchem Non-IDG -2.59278 381.0 264
Fibroblast growth factor 5 FGF5 Tbio Non-IDG -2.01948 99.9 143
Fibroblast growth factor 18 FGF18 Tbio Non-IDG -1.84518 76.6 133
Fibroblast growth factor receptor 3 FGFR3 Tclin Kinase -2.98083 995.1 350
Fibroblast growth factor 20 FGF20 Tbio Non-IDG -1.69038 53.1 104
Fibroblast growth factor 23 FGF23 Tchem Non-IDG -3.14174 1538.8 274
Fibroblast growth factor 17 FGF17 Tbio Non-IDG -1.59051 35.2 131